This online on-demand 23-minute seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Sweden. Available as pre-recorded webinar or full presentation in Acrobat PDF
Sweden is a common destination for innovative medical device companies.
Lack of specific reimbursement and funding barriers at national and regional level leaves decision-making about the introduction of novel technologies to hospitals. Global budget payment to hospitals also makes reimbursement challenge less relevant compared with other European countries.
Another attractive element of the system is one of the best patient registries, which enable detailed tracking of the use of technologies and outcomes research. Also, Sweden has the largest population among other Nordic countries and a good level of financing of the health care system.
However, despite the lack of formal barriers, physicians are very evidence-driven, which creates certain requirements for clinical and economic evidence. Also, the country has a large network of health technology assessment organizations, which can pose a challenge or opportunity during the introduction of a novel technology.
We offer a seminar on critical elements of the hospital reimbursement system for medical devices in Sweden that can guide your decision-making about the introduction of novel technologies into this market.
Key stakeholders are reviewed, including payers, policy-makers (National Board of Health and Welfare), advising organizations (health technology assessment, New Therapy Council) and support bodies (developer of procedural classification/DRG system, collector of cost information to inform DRG tariffs)
Money flow and distribution of funds, an overview of the hospital payment system (DRG system and global budget), the process of development of the DRG system
Overview of funding framework for medical technologies (e.g., coverage in the national guidelines of the National Board of Health and Welfare), HTA landscape at the national and regional level, the activity of HTA organizations, the status of the project on managed introduction of technologies into Swedish health care system
A separate comprehensive overview of the organizational and financing framework of screening methods (e.g. breast and cervical cancer screening) in Sweden
Some topics are not specifically covered in this seminar: reimbursement model in out-patient settings, reimbursement for medical aids (devices for home use) and in-vitro diagnostic tests, funding of capital equipment.
The introductory presentation also does not include details of reimbursement application processes (for example application form, requirements, details of the process for the creation of procedure code or DRG change).
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy.
One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 23 minutes. Seminar is available for 6 months
You can also access just the educational material - the full presentation of the seminar in Acrobat PDF
This 2-minute extract presents overview of the process of introduction of novel procedures into DRG system in Sweden